We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+26.41%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.88B
AUM Growth
+$2.09B
(+31%)
Cap. Flow
+$564M
Cap. Flow
% of AUM
6.36%
Top 10 Holdings %
Top 10 Hldgs %
40.05%
Holding
908
New
100
Increased
273
Reduced
455
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$76.1M |
| 2 |
Enterprise Products Partners
EPD
|
+$64.2M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$44.1M |
| 4 |
MPLX
MPLX
|
+$22M |
| 5 |
Plains All American Pipeline
PAA
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$23.3M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$21.9M |
| 3 |
Eastman Chemical
EMN
|
+$21.3M |
| 4 |
Duke Energy
DUK
|
+$20.8M |
| 5 |
Broadcom
AVGO
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 48.15% |
| 2 | Financials | 11.06% |
| 3 | Technology | 6.82% |
| 4 | Healthcare | 5.49% |
| 5 | Industrials | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
151
DELISTED
ChemoCentryx, Inc.
CCXI
| $7.71M | 0.09% |
124,523
+36,670
| +42% | +$2.1M |
|
152
Blink Charging
BLNK
$75.2M
| $7.64M | 0.09% |
178,671
+54,271
| +44% | +$1.07M |
|
153
Coeur Mining
CDE
$15.6B
| $7.58M | 0.09% |
732,116
-539,430
| -42% | -$4.43M |
|
154
PTC Therapeutics
PTCT
$6.37B
| $7.47M | 0.08% |
122,374
+36,031
| +42% | +$2.12M |
|
155
Vanguard Small-Cap Value ETF
VBR
$37.1B
| $7.46M | 0.08% |
52,471
-1,860
| -3% | -$240K |
|
156
Immunovant
IMVT
$8.09B
| $7.27M | 0.08% |
+157,400
| New | +$7.28M |
|
157
Liberty Broadband Class C
LBRDK
$4.15B
| $7.04M | 0.08% |
44,464
+10,714
| +32% | +$1.63M |
|
158
HDFC Bank
HDB
$119B
| $6.92M | 0.08% |
191,580
+7,000
| +4% | +$223K |
|
159
Vanguard Long-Term Bond ETF
BLV
$5.75B
| $6.81M | 0.08% |
62,090
+2,460
| +4% | +$274K |
|
|
MOR
160
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $6.74M | 0.08% |
237,797
+67,910
| +40% | +$1.86M |
|
161
Legend Biotech
LEGN
$4.3B
| $6.72M | 0.08% |
+238,602
| New | +$6.87M |
|
162
Visa
V
$677B
| $6.48M | 0.07% |
29,611
+770
| +3% | +$158K |
|
|
SWTX
163
DELISTED
SpringWorks Therapeutics
SWTX
| $6.28M | 0.07% |
86,616
+31,757
| +58% | +$2.04M |
|
164
Vir Biotechnology
VIR
$1.47B
| $6.15M | 0.07% |
229,652
+67,623
| +42% | +$2.2M |
|
165
Insmed
INSM
$23.2B
| $6.11M | 0.07% |
+183,428
| New | +$6.7M |
|
|
KYNB
166
Kyntra Bio
KYNB
$28.5M
| $6.06M | 0.07% |
6,533
+1,924
| +42% | +$2.02M |
|
167
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
| $6.02M | 0.07% |
111,345
-2,090
| -2% | -$113K |
|
|
PPLI
168
People Inc
PPLI
$3.1B
| $5.8M | 0.07% |
56,156
+8,263
| +17% | +$633K |
|
169
Alkermes
ALKS
$8.82B
| $5.74M | 0.06% |
+287,473
| New | +$5.26M |
|
170
Rocket Pharmaceuticals
RCKT
$348M
| $5.47M | 0.06% |
99,753
+29,372
| +42% | +$1.07M |
|
171
Cheniere Energy
LNG
$56.5B
| $5.46M | 0.06% |
90,947
+8,635
| +10% | +$463K |
|
172
Agios Pharmaceuticals
AGIO
$2.16B
| $5.41M | 0.06% |
+124,917
| New | +$4.94M |
|
173
Vanguard Small-Cap ETF
VB
$79.5B
| $5.35M | 0.06% |
27,469
-780
| -3% | -$138K |
|
|
BLUE
174
DELISTED
bluebird bio
BLUE
| $5.18M | 0.06% |
+9,241
| New | +$5.86M |
|
175
Targa Resources
TRGP
$60.4B
| $4.94M | 0.06% |
187,342
+37,645
| +25% | +$801K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, ALPS Advisors held 908 positions worth $8.88B, up 31% from $6.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
ALPS Advisors deployed $564M of net new capital in Q4 2020, opening 100 new positions and adding to 273 existing holdings. Its largest new stake was Genuine Parts: 212,300 shares worth $21.3M.
By sector, the portfolio is most concentrated in Energy at 48% of assets, up from 46% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was WestRock Company, an estimated $23.3M trimmed.
- ALPS Advisors's largest Q4 2020 buy was Genuine Parts: 212,300 shares worth $21.3M.
- ALPS Advisors added most to Energy Transfer Partners in Q4 2020, an estimated $76.1M increase.
- ALPS Advisors's biggest Q4 2020 reduction was WestRock Company, cutting an estimated $23.3M.
- ALPS Advisors fully exited Duke Energy in Q4 2020, selling an estimated $20.8M.
- ALPS Advisors's ten largest holdings make up 40% of its $8.88B portfolio in Q4 2020.
- ALPS Advisors opened 100 new positions and closed 75 in Q4 2020.
- ALPS Advisors's portfolio value rose 31% quarter-over-quarter to $8.88B.
Based on ALPS Advisors's 13F filing for Q4 2020, filed 3 Feb 2021.